|
Rachell Mullen is a research associate at the
University of Manchester school of pharmacy
|
What is a primary care pharmacist? That was the question that opened the primary care session at the British Pharmaceutical Conference earlier this year. A wide variety of job titles were offered, including pharmaceutical adviser and prescribing support pharmacist. Similarly, several different, and in some cases opposing, definitions were volunteered. One member
of the panel defined primary care pharmacists as “pharmacists employed
within the National Health Service delivering primary care services’;
another provided a much broader definition, which extended to include
community pharmacists.
Consequently, time was spent debating the meaning of “primary care
pharmacist” and a shared sense of frustration arose from the fact
that the term means different things to different people and that no
one definition or job title truly encapsulates the role. It is therefore
unsurprising that pharmacists working outside the primary care sector
struggle to understand this new type of pharmacist, described recently
by the National Prescribing Centre as those who work in general practice,
primary care groups, primary care trusts and health authorities on a
part-time, full-time or sessional basis.
Indeed, during the course of the BPC session, some spoke of the existing
tensions between community and primary care pharmacy arising from a lack
of understanding of each other’s roles, which, in turn, were perceived
by most participants as being mutually exclusive.
The newer role of the primary care pharmacist appears confusing because
of the way that it evolved, from health authority- and general practice-based
pharmacists doing prescribing analysis in the early 1990s to one which
now involves working for different primary care organisations and undertaking
diverse and wide-ranging tasks. Current variations in the structure and
organisation of PCTs led to diversity in job titles and descriptions.
This is further complicated by the cross-sectoral mobility displayed
by almost two-thirds of primary care pharmacists who are portfolio workers,
namely, those who have more than one job, as revealed by the 2002 pharmacy
workforce census commissioned by the Royal Pharmaceutical Society.
Clearly, there are many dimensions to the role of pharmacists working
in primary care, which makes them a heterogeneous group within pharmacy.
However, the nature of this heterogeneity is not reflected by the all-encompassing
and popular generic title of “primary care pharmacist”. Taking
community pharmacy as an example to illustrate the point, pharmacists
in this sector can hold a variety of positions: proprietor/owner, locum
or second pharmacist. Similarly, for a hospital pharmacist, the grade
of their post broadly identifies their level of responsibility and hence
the type of job they perform. These community and hospital pharmacy “labels” convey
meanings that are relatively easy to understand by others working outside
that sector, or indeed, outside pharmacy. However, equivalent “labels” for
pharmacists working in primary care are much less clear. This is largely
because of the relative newness of primary care as an area of practice
for pharmacists, which has also developed within the context of a changing
policy environment.
Even before the inception of PCGs in 1999 and PCTs the following year,
Jesson and Wilson recognised that the emerging primary care pharmacist
role was “muddled and ill-defined” and required “conceptual
clarity”.1 Based on pharmacists working in general practices, the
authors developed a five-point functional model for the role of the primary
care pharmacist:
Level 1 — educational outreach
Level 2 — sessional target
Level 3 — consultancy
Level 4 — primary care pharmacist
Level 5 — health centre pharmacy and pharmacist
Starting from Level 1 and working up to the next level in the model,
pharmacists increase their time spent in the practice and gain greater
autonomy over the development of their role and the work they undertake,
which broadens beyond delivering key prescribing messages to meeting
proactively the wider needs of the practice. Several key factors were
identified by the authors as underlying the model and included place,
time, target audience, agenda and focus of task. The model was intended
to be dynamic, given the imminent arrival of new primary care organisations
and the numerous and different employment opportunities that they would
create for pharmacists.
The NPC model for the role of the primary care pharmacist reflects the
policy environment and NHS structure in 2000. Meanwhile, the model by
Jesson and Wilson specifically considers “general practice-based” pharmacists.
Findings from doctoral research that I undertook on the primary care
pharmacy workforce in England (2001/02) suggest that the role of the
primary care pharmacist is appropriately characterised by more descriptive
titles or typologies.2 Five typologies were developed, based on a primary
care pharmacist’s location of work, level within primary care and
the type of activities undertaken. The typologies were also informed
by the primary care pharmacist’s sociodemographic characteristics,
workforce mobility and reasons for taking up the primary care role. Unlike
in previous models, the typologies were developed from primary source
data drawn from approximately two-fifths of the primary care pharmacy
and are as follows:
General practice-based
P- and primary care trust-based
PCT-based
Health authority-based
Mixed (primary care pharmacists
who work for a variety of health care organisations)
These new typologies are a snapshot of the developing role of the primary
care pharmacist. Since this work was undertaken two years ago, NHS organisation
has changed in keeping with “Shifting the balance of power” and
the document “A vision for pharmacy” has been published.
Significantly, PCTs are now responsible for commissioning pharmaceutical
services locally in all sectors, not simply GP-based activities, and
senior pharmacists working in both strategic health authorities and PCTs
are more akin to pharmaceutical officers 10 years ago.
The answer to the question “what is a primary care pharmacist?” is
complicated because the role is evolutionary and multifaceted. It is
therefore not surprising that the role seems ambiguous and confusing
and, unlike community or hospital pharmacy, primary care does not currently
offer a traditional, linear career pathway in pharmacy. However, it now
seems unhelpful to continue to consider pharmacists who work in NHS authorities,
and pharmacists who work wholly or part of their time in GP practices
within the same workforce sector, ie, primary care pharmacy. Perhaps
simple generic titles of “pharmaceutical advisers” in the
former and “practice pharmacists” in
the latter would bring much needed clarity to these relatively new areas
of pharmacy practice.
References
1. Jesson J, Wilson K. Primary care pharmacists:
a conceptual model. Pharm J 1999;263:62–4.
2. Mullen R. Primary care pharmacy workforce [PhD thesis]. University
of Manchester; 2003. |
|